Cargando…
Synergistic Interactions of Cannabidiol with Chemotherapeutic Drugs in MCF7 Cells: Mode of Interaction and Proteomics Analysis of Mechanisms
Cannabidiol (CBD), a nonpsychoactive phytocannabinoid, has recently emerged as a potential cytotoxic agent in addition to its ameliorative activity in chemotherapy-associated side effects. In this work, the potential interactions of CBD with docetaxel (DOC), doxorubicin (DOX), paclitaxel (PTX), vino...
Autores principales: | Alsherbiny, Muhammad A., Bhuyan, Deep J., Low, Mitchell N., Chang, Dennis, Li, Chun Guang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469885/ https://www.ncbi.nlm.nih.gov/pubmed/34576262 http://dx.doi.org/10.3390/ijms221810103 |
Ejemplares similares
-
Metabolomic Identification of Anticancer Metabolites of Australian Propolis and Proteomic Elucidation of Its Synergistic Mechanisms with Doxorubicin in the MCF7 Cells
por: Alsherbiny, Muhammad A., et al.
Publicado: (2021) -
Drug–Drug Interactions of Cannabidiol with Standard-of-Care Chemotherapeutics
por: Buchtova, Tereza, et al.
Publicado: (2023) -
Mechanistic Insights into the Anti-Proliferative Action of Gut Microbial Metabolites against Breast Adenocarcinoma Cells
por: Jaye, Kayla, et al.
Publicado: (2023) -
Medicinal Cannabis—Potential Drug Interactions
por: Alsherbiny, Muhammad A., et al.
Publicado: (2018) -
The Odyssey of Bioactive Compounds in Avocado (Persea americana) and Their Health Benefits
por: Bhuyan, Deep Jyoti, et al.
Publicado: (2019)